Executive Decisions
Novonesis CEO Ester Baiget reflects on the decision to leave Dow after 25 years to lead Novozymes, and why impact, not ambition, drove the move. She discusses the family values that shaped her, redefining the company as a biosolutions leader, the Chr. Hansen merger and why leadership requires courage, respect and long-term purpose.
Executive Decisions airs on CNBC UK at 9:00 AM, Sunday 28 June.
Topics
Education ➝ Science ➝ Factual Topics
General